medline.ch Gynäkologie Mammae

	Associations Between Physical Activity Measurement Modality and Gut Microbiome in Breast Cancer Survivors. Nutrients Neal WN, Kemp KM, Little RB, Carter SJ, Schleicher EA, Motl RW, Lu J, Lefkowitz EJ, Oster RA, Norian LA, Hunter GR, Krontiras H, Turan B, Rogers LQ. PMID: 42884737 [PubMed - indexed for MEDLINE]
	Dietary Calcium Intake in Patients Evaluated for Bone Fragility, with a Focus on Women Receiving Adjuvant Endocrine Therapy for Breast Cancer: A Single-Center Cross-Sectional Study. Nutrients Firmani F, Ciarloni A, Sabatelli S, Gianfelice C, Salvio G, Agostinelli V, Berardi R, Balercia G, Giacchetti G. PMID: 42884689 [PubMed - indexed for MEDLINE]
	The Association Between Pre-Pregnancy Excess Weight and the Omega-6/Omega-3 Ratio in Breast Milk: A Directed Acyclic Graph-Based Analysis. Nutrients Marano D, Mazzoli F, Ferreira CDS, da Costa ACC, Vilarim M, Conceição LVA, Pereira EDS, de Sousa TM, da Silva LML, El-Bacha T. PMID: 42884670 [PubMed - indexed for MEDLINE]
	Nanoparticle-Enabled Immune-Dose Shaping in Breast Cancer Radiotherapy: Reconciling Tumor Immunogenicity with Systemic Immune Preservation. Int J Mol Sci Lunca S, Morarasu S, Dimofte GM. PMID: 42884170 [PubMed - indexed for MEDLINE]
	HBOCpred: An Ensemble Framework for Prioritisation of Germline Missense Variants in Hereditary Breast and Ovarian Cancer. Int J Mol Sci Alay MT, Erdem HB. PMID: 42884108 [PubMed - indexed for MEDLINE]
	Dynamic Immune Responsiveness in Breast Cancer: Tumor Microenvironment Plasticity, Therapeutic Timing, and Clinical Translation. Int J Mol Sci Udden SMN, Obaid M, Pop LM, Hannan R. PMID: 42884096 [PubMed - indexed for MEDLINE]
	Molecular Proliferation Marker Ki-67 in Breast Cancer: The Role of Vitamin D Status, Hormone Receptor Expression, and Clinicopathological Factors-A Cross-Sectional Study. Int J Mol Sci Weber D, , Pacian A, Kulik T, Bary. PMID: 42884041 [PubMed - indexed for MEDLINE]
	Targeting Aromatase and HDACs in Hormone Receptor-Positive Breast Cancer: Molecular Interplay, Endocrine Resistance and Therapeutic Opportunities. Int J Mol Sci Lucaciu RL, Hangan AC, Oprean LS, Procopciuc LM. PMID: 42883867 [PubMed - indexed for MEDLINE]
	MCOF: A Multi-Channel Attention-Based Omics Fusion Framework for Cancer Subtyping and Candidate Biomarker Prioritization. Int J Mol Sci Liang X, Wang Q, Xie K, Zhang J, Feng S, Zhong X, Guo T, Zhang Y, Chen W. PMID: 42883767 [PubMed - indexed for MEDLINE]
	Lipid Composition in the Breast of Premenopausal BRCA1/2 Genetic Mutation Carriers Using MRI. Int J Mol Sci Cheung SM, Chan KS, Ragupathy S, Miedzybrodzka Z, He J. PMID: 42883719 [PubMed - indexed for MEDLINE]
	The Effects of Physical and Mind-Body Exercise on Anxiety Among Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Controlled Trials. Cancers (Basel) Süleymano, Eyip, Pancar Z, Stefanica V, Bragazzi NL, Ceylan H. PMID: 42882937 [PubMed]
	Multi-Omics and Liquid Biopsy Integration for Precision Stratification of Breast Cancer. Cancers (Basel) Sharma D, Srivastava S, Sridhar SB, Shareef J, Sahu R, Budha RR, Tariq M, Kamal MA. PMID: 42882929 [PubMed]
	Choosing Between Anti-TROP2 ADCs in Advanced Breast Cancer Without Head-to-Head Evidence: A Practical Evidence-Informed Decision Framework Endorsed by the Polish Society of Clinical Oncology. Cancers (Basel) Wysocki PJ, Pogoda K, Wysocka E, Radecka B, Krzakowski M. PMID: 42882921 [PubMed]
	Combined Use of Savi Scout and Magtrace for Non-Palpable Breast Cancer: A Retrospective Study. Cancers (Basel) Lloyd-Davies C, Kasem A. PMID: 42882892 [PubMed]
	Quality-of-Life and Weight Loss Outcomes Following an Individualized Nutrition and Physical Activity Counseling Program in Breast Cancer Survivors: A Prospective Single-Arm Pilot Study. Cancers (Basel) Kant S, Alhalabi A, Bilani N, Jabbal IS, Herrán M, Abdo T, Sabbagh S, Sarna K, Stevenson A, Saravia D, Schwartz C, Samuel T, Nahleh Z, Stone E. PMID: 42882891 [PubMed]
	Mediterranean Diet Adherence Tools in Post-Treatment Breast Cancer Survivors: A Scoping Review of Measurement Approaches and Associated Outcomes. Cancers (Basel) Johnston KE, Twomey AM, Cushen SJ. PMID: 42882879 [PubMed]
	Prognostic Markers in Triple-Negative Breast Cancer (TNBC). Cancers (Basel) Shah I, Naik S, Arfuso F, Warrier S, Dharmarajan A, Manohar SM. PMID: 42882876 [PubMed]
	Histological Subtype Provides Limited Prognostic Information in Grade 1 Invasive Breast Carcinoma: A Retrospective Cohort Study. Cancers (Basel) Locher E, Benning L, Varga Z. PMID: 42882846 [PubMed]
	Functional Deconstruction of AC-T Chemotherapy Reveals Interindividual Heterogeneity and Independent Drug Action in Breast Cancer. Cancers (Basel) Simões LD, Santos GL, Carvalho PO, Santos EXD, Canteli ARA, Morales Junior R, Saccarelli CR, Moysés LAJ, Yamashita LA, Akissue de Camargo Teixeira P, Kobayashi TY, Ferreira VCCS, Omura VLN, Almeida LS, Anjos CHD, Barros ACSD, Camargo AA, Bevilacqua JLB, Giannotti DG, Costa ÉT. PMID: 42882816 [PubMed]
	Preclinical-Clinical Discrepancies in Immune Checkpoint Inhibitor Efficacy for Triple-Negative Breast Cancer: Disease Stage, Antibody Properties, Biomarker Alignment, and Model Limitations. Cancers (Basel) Zhang Y, Paing H, Wang J. PMID: 42882794 [PubMed]

Artikel 1 - 20 / 223118

Seite 1 von 11156

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung